COR Q4 2020 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q4 2020 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$49.2B+7.9% YoY

Gross Profit

$1.2B2.5% margin

Operating Income

$528M1.1% margin

Net Income

-$4.8B-9.8% margin

EPS (Diluted)

$-23.74

QoQ Revenue Growth

+8.5%

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.2B

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$44.3B

Total Liabilities

$45.1B

Stockholders' Equity

-$1.0B

Cash & Equivalents

$4.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49.2B	$45.6B	+7.9%
Gross Profit	$1.2B	$1.1B	+16.4%
Operating Income	$528M	$351M	+50.4%
Net Income	-$4.8B	$133M	-3754.1%

Revenue Segments

Pharmaceutical Distribution

$47.3B96%

Other Segments

$2.0B4%

Geographic Segments

Other Segments

$2.0B100%